References
- TemperoMABerlinJDucreuxMPancreatic cancer treatment and research: An international expert panel discussionAnn Oncol2011221500150621199884
- JemalASiegelRXuJQWardECancer Statistics, 2010CA Cancer J Clin20106027730020610543
- NakaiYIsayamaHSasakiTComorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapyCrit Rev Oncol Hematol20117825225920579902
- GuoQLYouQDWuZQYuanSTZhaoLGeneral gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude miceActa Pharmacol Sin20042576977415169630
- YuJGuoQLYouQDGambogic acid-induced G(2)/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cellsCarcinogenesis20072863263817012222
- KasibhatlaSJessenKAMaliartchoukSA role for transferrin receptor in triggering apoptosis when targeted with gambogic acidProc Natl Acad Sci U S A2005102120951210016103367
- WuZQGuoQLYouQDZhaoLGuHYGambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cellsBiol Pharm Bull2004271769177415516720
- ZhuXZhangCWuXLPreparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivativesDrug Dev Ind Pharm2008342918214750
- WangJQSuiMHFanWMNanoparticles for tumor targeted therapies and their pharmacokineticsCurr Drug Metab20101112914120359289
- ZhangHJChenBAJiangHWangCLWangHPWangXMA strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials2011321901914
- ChenBAChengJShenMFMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
- ChenBAMaoPPChengJReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cellsInt J Nanomedicine2010543744420957165
- WuWWChenBAChengJBiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
- WangJChenBAChengJApoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles coloaded with daunorubicin and 5-bromotetrandrinInt J Nanomedicine201161027103421720514
- WangJChenBAChengJSynthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticlesInt J Nanomedicine2011620321121445276
- ChenBALiangYQWuWWSynergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cellsInt J Nanomedicine2009425125920011242
- ZhangDWZhangHNieJYangJSynthesis and self-assembly behavior of pH-responsive amphiphilic copolymers containing ketal functional groupsPolym Int201059967974
- BarefordLASwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Delivery Rev200759748758
- YooHSLeeKHOhJEParkTGIn vitro and in vivo anticancer activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release20006841943110974396
- LinBLShenXDCuiSApplication of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release propertiesBiomed Mater2007213213418458446
- FeckerLFGeilenCCTchernevGLoss of proapoptotic Bcl-2- related multidomain proteins in primary melanomas is associated with poor prognosisJ Invest Dermatol20061261366137116528364
- YangEKorsmeyerSJMolecular thanatopsis: A discourse on the BCL2 family and cell deathBlood1996883864018695785
- GhavamiSHashemiMAndeSRApoptosis and cancer: Mutations within caspase genesJ Med Genet20094649751019505876